Cohen & Steers names Andrew Shin to lead S.Korea institutional business
US-based investment firm Cohen & Steers Inc. has appointed Andrew Shin, a 20-year veteran of the institutional investment market, as vice presid...
Lotte Biologics signs antibody drug CMO deal with UK’s Ottimo Pharma
BOSTON – Lotte Biologics Co. has signed a deal to manufacture an antibody therapy for British biotech startup Ottimo Pharma as the South Korea...
S.Korea’s CDMO giant Samsung Biologics to offer CRO services
Samsung Biologics Co., the world’s largest contract drugmaker, will enter the contract research organization (CRO) market by leveraging its va...
Samsung Biologics drives foreign lead in Korea’s biotech supply chain
A surge in orders from Samsung Biologics Co., the world’s largest contract drugmaker, has propelled South Korea to the forefront of global rev...
Samsung Biologics to spin off biosimilar unit Samsung Bioepis
Samsung Biologics Co., the world’s largest contract drugmaker, will undergo a strategic split to separate its contract development and manufac...
Korean financial firms launch global IR blitz to woo foreign capital
Chiefs of South Korea’s major financial groups – Shinhan, Woori and iM – are ramping up global investor outreach with new sharehol...
Samsung Biologics bags $514 mn CMO contract from US pharma
Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO), said on Monday it has secured a $5.14 million order from...
NPS pours $3.9 bn to buttress Korean stock market
South Korea’s National Pension Service, the country’s largest institutional investor, has come to the rescue of the domestic stock marke...
Strong momentum in non-US markets, digital real estate: Principal AM CEO
It is time to shift focus toward non-US markets after years of stellar performance of US assets driven by the robust world’s No. 1 economy, sa...
South Korea’s pension fund NPS risks massive loss from Homeplus fiasco
South Korea’s National Pension Service (NPS), the nation’s biggest institutional investor, could lose more than 1 trillion won ($692 mil...
Chong Kun Dang to build new plant for foray into biologics market
Chong Kun Dang Pharmaceutical Corp. is discussing building a research center and a plant in Siheung, about 30 kilometers southwest of Seoul, with th...
Korean tractor maker Daedong ends two-decade partnership with Deere
Daedong Corp., South Korea’s leading tractor and farm machinery maker, has ended its two-decade-long partnership with Deere & Co., the wor...
Samsung Biologics shares fly high to be Korea’s third most valuable firm
Samsung Biologics Co., the world’s largest contract drugmaker, has become South Korea’s third most valuable stock on the country’s...
Korean exports snap 15 months of gains in Jan despite higher chip sales
South Korea’s exports dropped in January on-year for the first time in 16 months due to more holiday days in the month, although overseas sale...
Samsung Biologics posts record 2024 sales, operating profit as it goes global
South Korea's Samsung Biologics Co., the world’s largest contract drugmaker, on Wednesday posted its largest-ever annual sales and operating p...
Lotte Biologics eyes first ADC CDMO order in 2025
SAN FRANCISCO -- Lotte Biologics Co., the drug consignment development and production unit of South Korean conglomerate Lotte Group, will seek to wi...
Samsung Biologics signs $1.4 bn CMO deal with European pharma
South Korea's Samsung Biologics Co., the world’s largest contract drugmaker, said on Tuesday it signed a $1.4 billion contract manufacturing o...
Samsung Biologics signs initial deal with LigaChem Bio on ADC production
Samsung Biologics Co., the world’s largest contract drugmaker, said on Thursday it has signed an initial agreement with LigaChem Biosciences I...
Korea Inc. to face refunding risks with record corporate bond maturities
South Korean companies are expected to face refunding risks thanks to record corporate bond maturities in the first half of 2025, as fundraising con...
NPS enjoys 9.2% return as of Q3 on bullish US stocks
The National Pension Service (NPS), South Korea’s largest institutional investor, reported a preliminary 9.18% return from investments, equiva...
Samsung Biologics wins $668 million CDMO deal with European pharma
Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it has signed two drug manufacturing contracts worth a combin...
US private equity giant Apollo opens Seoul office for APAC expansion
Apollo Global Management Inc., a US private equity powerhouse, said on Monday it has opened an office in Seoul to expand its business in the Asia Pa...
State-run think tank KDI slashes GDP forecast, urges BOK to cut rates
The Korea Development Institute (KDI), South Korea’s state-run think tank, has slashed its forecasts for the country’s economic growth f...
Daedong opens autonomous robot subsidiary Daedong Robotics
Daedong Group, South Korea's leading agricultural machinery manufacturer, said on Monday it established Daedong Robotics, an intelligent autonomous ...
SK Broadband to launch nationwide dedicated line service in S.Korea
South Korea's SK Broadband said on Thursday that it will establish a nationwide network using Internet Protocol-Multi Protocol Label Switching (IP-M...
NPS signals more say in Hanmi Pharmaceutical's family feud
South Korea’s National Pension Service is indicating more active involvement in the management of Hanmi Pharmaceutical Group embroiled in a ye...
Shinhan Card tops S.Korea's EPG ranking for financial institutions
South Korea's Shinhan Card said on Monday it was ranked as the leading company in the domestic financial sector in an environment, population, and g...
IMBiologics transfers autoimmune disease drug tech to Huadong Pharma
South Korea's antibody-based biotech company IMBiologics announced on Friday that it signed a contract to transfer the technology of its autoimmune ...
Biotech stocks, foreigners’ top pick in Korea amid panic selling
Foreigners and institutional investors in the South Korean stock market picked biotechs as their favorite shares in hopes of a biopharma stock jump ...
Orion to collaborate with Vietnam on potato seed
South Korea’s Orion Corp. announced on Monday that it is strengthening its collaboration with the Institute of Agro-Biology, the Vietnam Natio...
